Skip to main content
Filing year 2024

IMMUNE DEFICIENCY FOUNDATION

Hanover, Maryland·EIN 52-1214782·NTEE H9CZ · Medical Research·3
Total revenue
$10.1M
Total assets
$18.8M
Total expenses
$0
Reported officers
19
Mission

THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE FOR EVERY PERSON AFFECTED BY PRIMARY IMMUNODEFICIENCY. WE FOSTER A COMMUNITY THAT IS CONNECTED, ENGAGED, AND EMPOWERED THROUGH ADVOCACY, EDUCATION, AND RESEARCH.

Executive compensation, broken down

Form 990 · Schedule J · 7 reported individuals · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
$347k
VP Instituti
vice president
$178k
CTO
highest compensated employee
$173k
VP Communica
vice president
$171k
VP Public Po
vice president
$166k
Director of
highest compensated employee
$156k

Plus 12 unpaid individuals.

Browse compensation in Medical Research

Up 16%
from 2023

From $301k in 2023 to $347k in 2024.

$301k
2023
$347k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.